Kenda Alkwatli, MD
NPI 1063075901ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Wethersfield, CT
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Wethersfield, Connecticut, trained at University of Connecticut School of Medicine (class of 2022). Part D covered 123 prescriptions written in 2024, 32% of them generic. Novo Nordisk Inc was the largest of 19 companies reporting payments in 2025, $1,271 in all, mostly food and beverage.
Overview
| NPI | 1063075901 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 16, 2019 |
| Last updated in NPPES | Sep 19, 2024 |
| Certified by provider | Sep 19, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | 79002 | CT |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (CT) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 123 · 245 30-day fills |
|---|---|
| Patients | 36 |
| Total drug cost | $59,574 |
| Generic share | 32% of claims |
Education and affiliations
| Medical school | University of Connecticut School of Medicine |
|---|---|
| Graduation year | 2022 |
| Medicare specialty | Endocrinology |
| Telehealth | Offers telehealth |
Medical group
- Starling Physicians, PLLCWethersfield, CT · 283 clinicians
Industry payments (Open Payments)
- 2025$1,271 · 59 payments from 19 companies
- 2024$268.28 · 3 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $221.20 | 14 |
| Amgen Inc. | $133.01 | 5 |
| Medtronic, Inc. | $131.96 | 2 |
| Xeris Pharmaceuticals, Inc. | $126.44 | 6 |
| Lilly USA, LLC | $123.89 | 8 |
What the 2025 payments were for
- Food and Beverage$1,271 · 59 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records